Synergy Pharmaceuticals Incorporated (SGYP)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.01 / 0.04
Exchange NASDAQ
Div & Yield N.A. (N.A)
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Synergy Pharmaceuticals Inc. Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Synergy Pharmaceuticals Inc. Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results And Business Update

Synergy Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results And Business Update

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and business update for...

The Klein Law Firm Announces The Commencement Of A Class Action On Behalf Of Synergy Pharmaceuticals Inc. Shareholders And A Lead Plaintiff Deadline Of April 10, 2018

The Klein Law Firm Announces The Commencement Of A Class Action On Behalf Of Synergy Pharmaceuticals Inc. Shareholders And A Lead Plaintiff Deadline Of April 10, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Synergy Pharmaceuticals Inc.

SGYP INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Synergy Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of April 10, 2018

SGYP INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Synergy Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of April 10, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of investors who purchased Synergy Pharmaceuticals...

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Synergy Pharmaceuticals Inc. Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Synergy Pharmaceuticals Inc. Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Synergy Pharmaceuticals Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Synergy Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Synergy Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of...

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Synergy Pharmaceuticals Inc. (SGYP)

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Synergy Pharmaceuticals Inc. (SGYP)

The Klein Law Firm announces the commencement of an investigation of Synergy Pharmaceuticals Inc.

Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Lawsuit Filed Against Synergy Pharmaceuticals Inc.

Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Lawsuit Filed Against Synergy Pharmaceuticals Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Synergy Pharmaceuticals Inc.

SYNERGY PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Synergy Pharmaceuticals, Inc. To Contact The Firm

SYNERGY PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Synergy Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synergy Pharmaceuticals, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Synergy Pharmaceuticals Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Synergy Pharmaceuticals Inc.

The Klein Law Firm announces the commencement of an investigation of Synergy Pharmaceuticals Inc.

SGYP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Synergy Pharmaceuticals Inc.

SGYP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Synergy Pharmaceuticals Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Synergy Pharmaceuticals Inc.

SGYP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Synergy Pharmaceuticals Inc.

SGYP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Synergy Pharmaceuticals Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Synergy Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that the Compensation Committee of the Board...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. - SGYP

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. - SGYP

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals Achieves Cash Balance Requirement To Access Additional Capital

Synergy Pharmaceuticals Achieves Cash Balance Requirement To Access Additional Capital

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that it has met the cash balance...

Interesting SGYP Put And Call Options For March 16th

Interesting SGYP Put And Call Options For March 16th

Investors in Synergy Pharmaceuticals Inc saw new options begin trading this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP options chain for the new March 16th contracts and identified one put and one call contract of particular interest.

The January Effect Is on Time This Year

The January Effect Is on Time This Year

I continue to believe that biotech and biopharma stocks will outperform in 2018.

Interesting SGYP Put And Call Options For February 2018

Interesting SGYP Put And Call Options For February 2018

Investors in Synergy Pharmaceuticals Inc saw new options become available this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

Gary S. Jacob, Ph.D., Executive Chairman, Synergy Pharmaceuticals Inc. (Photo: Business Wire)

Gary S. Jacob, Ph.D., Executive Chairman, Synergy Pharmaceuticals Inc. (Photo: Business Wire)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that Troy Hamilton, Pharm.

First Week of SGYP July 2018 Options Trading

First Week of SGYP July 2018 Options Trading

Investors in Synergy Pharmaceuticals Inc saw new options begin trading this week, for the July 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Synergy Pharmaceuticals Announces Pricing Of Offering Of Common Stock And Warrants

Synergy Pharmaceuticals Announces Pricing Of Offering Of Common Stock And Warrants

Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today announced the pricing of its underwritten offering of...

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results And Business Update

Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results And Business Update

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and business update for...

4 Small-Caps on My Earnings Watch List

4 Small-Caps on My Earnings Watch List

We are coming my favorite part of earnings season -- when these small-caps report.

Synergy Pharmaceuticals To Report Third Quarter 2017 Financial Results And Host Conference Call And Webcast

Synergy Pharmaceuticals To Report Third Quarter 2017 Financial Results And Host Conference Call And Webcast

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced it intends to release third quarter 2017 financial results after the NASDAQ market close on Thursday, November 9, 2017.